Full Text
Cost-Effectiveness Analysis of Sunitinib Versus Interferon Alfa for the First-Line Treatment of Advanced And/Or Metastatic Renal Cell Carcinoma in Singapore

Abstract

Authors

S Pruis F Pearce MI Abdul Aziz DB Wu KH Ng

Back to Volume 21, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×